MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202541003724 A) filed by Yenepoya Deemed To Be University on January 16, 2025, for Mass Spectrometry-Based Assay System For Identification Of Immunotherapeutic Targets.
Inventors include Dr. M. Vijayakumar; Dr. T. S. Keshava Prasad; Dr. Rohan Shetty; Dr. Jalaluddin Akbar K. C.; Dr. Rohan Thomas Mathew; Ms. Anjana Aravind; Ms. Akhina Palollathil; Ms. Anagha Kanichery; and Mr. Chinmaya Narayana Kootimoole.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: ABSTRACT MASS SPECTROMETRY-BASED ASSAY SYSTEM FOR IDENTIFICATION OF IMMUNOTHERAPEUTIC TARGETS The present disclosure relates to the mass spectrometry-based assay system for the identification and quantification of immunotherapeutic targets from cancer subjects. More particularly, the disclosure involves Data-Independent Acquisition-Mass Spectrometry (DIA), Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS) , and Parallel Reaction Monitoring-Mass Spectrometry (PRM-MS) methods for the identification of a panel of immunotherapeutic proteins comprising PDCD1 (PD-1), CTLA4, TIM3, LAG3, CD20 (MS4A1), CD27, PDCD1L1 (PD-L1), PDCD1L2 (PD-L2), CD70 (TNFSF7), CD40 (TNFRSF5), CD155 (PVR) and MUC1 from peripheral blood mononuclear cell (PBMC) samples and tumour tissue samples of cancer subjects.
Disclaimer: Curated by HT Syndication.
